| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 22, 2003 |
Director
Trans History: 312
|
Director | Form 5 | Bona fide gift | 1,000 | -- | 25,975 |
| Dec 22, 2003 |
Director
Trans History: 312
|
Director | Form 5 | Bona fide gift | 1,000 | -- | 24,975 |
| Dec 22, 2003 |
Director
Trans History: 312
|
Director | Form 5 | Bona fide gift | 1,000 | -- | 23,975 |
| Dec 18, 2003 |
Director
Trans History: 312
|
Director | Form 4 | Conversion of derivative security | 25,000 | -- | 27,975 |
| Dec 18, 2003 |
Director
Trans History: 312
|
Director | Form 4 | Conversion of derivative security | 25,000 | -- | 76,237 |
| Dec 17, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 200,000 |
| Dec 15, 2003 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,708 | -- | 31,108 |
| Dec 15, 2003 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,692 | -- | 7,692 |
| Dec 15, 2003 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,308 | -- | 67,308 |
| Dec 15, 2003 |
VP, Clinical Sciences
Trans History: 37
|
VP, Clinical Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,077 | -- | 12,124 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.